Rocío Ramos‐Medina

Author

Rocío Ramos‐Medina

Hospital General Universitario Gregorio Marañón ORCID

Also Known As

R Ramos, R. RAMOS, R. Ramos, R. Ramos-Medina, Rocio Ramos-Medina, Rocio Ramos‐Medina, Rocío Ramos, Rocío Ramos-Medina, Rocío Ramos‐Medina

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Hospital General Universitario Gregorio Marañón Hospital Clínico San Carlos Instituto Nacional de Enfermedades Neoplásicas Hospital Ruber Internacional Inserm

About

Rocío Ramos‐Medina is an author at Hospital General Universitario Gregorio Marañón specializing in medicine, molecular diagnostics, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	818
2	Health Sciences	1	1	54
3	Biostatistics	1	1	107
4	Cell Biology	1	1	56
5	Clinical Immunology	1	1	56

Rocío Ramos‐Medina

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma Iñaki Comino‐Méndez, Francisco Javier Gracia-Aznárez, Francesca Schiavi, Nature Genetics Hereditary PheochromocytomaMendelian DisorderGenetic DisorderMedicineGenetics	2011	524
Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification Isabel Echavarría, Sara López‐Tarruella, Antoni C. Picornell, Clinical Cancer Research Breast OncologyReliable PredictorsMedicineMetronomic TherapyNeoadjuvant Carboplatin	2018	107
Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a <scp>S</scp>panish Cohort of Women with Recurrent Reproductive Failure and Expanded <scp>CD</scp>56<sup>+</sup> Cells Manuela Moraru, Javier Carbone, Diana Alecsandru, American Journal of Reproductive Immunology	2012	100
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors Iván Márquez‐Rodas, Federico Longo, María E. Rodríguez-Ruiz, Science Translational Medicine	2020	80
Experience in <scp>IVI</scp>g Therapy for Selected Women with Recurrent Reproductive Failure and <scp>NK</scp> Cell Expansion Rocío Ramos‐Medina, Áurea García‐Segovia, Juana Gil, American Journal of Reproductive Immunology	2014	64
Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series Antoni C. Picornell, Isabel Echavarría, Enrique L. Álvarez, BMC Genomics	2019	57
New regulatory CD19+CD25+ B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids Clara de Andrés, Marta Tejera‐Alhambra, Bárbara Alonso, Journal of Neuroimmunology Clinical ImmunologyMultiple Sclerosis RelapseIsolated SyndromeAutoimmune DiseaseMedicine	2014	56
Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis Marta Tejera‐Alhambra, Armanda Casrouge, Clara de Andrés, PLoS ONE Disease ProgressionImmunologyNeurological ProgressImmune SystemInflammation	2015	54
SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms Santiago Montes‐Moreno, Rocío Ramos‐Medina, Azahara Martínez-López, Blood	2012	50
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial Milagros González‐Rivera, Miriam Lobo, Sara López‐Tarruella, Breast Cancer Research and Treatment Breast OncologyCancer PathologyUnselected Prospective CohortMedicineGenetics	2016	40

Page 1